英国牛津大学招聘地中海贫血症和贫血炎症治疗干预研究博士后

We are seeking a Postdoctoral Scientist to undertake the development and pre-clinical testing of novel therapeutic interventions aiming to i) prevent iron overload of non-transfusion dependent thalassaemia and ii) treat anaemia of inflammation. This post will form part of a team working on a new project funded by Pfizer as part of the Rare Disease Consortium in Oxford.

The successful candidate will be working within Professor Hal Drakesmith’s research group which has a strong record of attracting external grant funding, a strong publication record, and has expanded significantly in recent years. They aim to foster scientific excellence within a friendly, open and free-thinking environment. The work is funded by Pfizer and will be performed in close collaboration with Pfizer and the laboratory of Professor Simon Draper at the Jenner Institute in Oxford.

The successful candidate must have relevant high-level expertise at PhD or postdoctoral level. Previous experience of molecular biology techniques, sterile primary cell culture, animal models of iron disorders and investigations into human iron homeostasis would be important.

The position will be based primarily at the Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, UK. Informal enquiries about this post can be addressed to: Hal Drakesmith hdrakes@hammer.imm.ox.ac.uk

The Postdoctoral Scientist position is fixed-term for up to 2.5 years initially. Applications from candidates who have not yet completed their PhD will be considered, to be appointed at Grade 6 (£27,057 – £32,277 p.a.) with amended duties and responsibilities.

Applications for this vacancy are to be made online. You will be required to upload a supporting statement and CV as part of your online application.

Only applications received before 12.00 midday on Thursday 30 April 2015 will be considered.